HbA1c adjusted by erythrocyte creatine is a useful glycemic control indicator in patients with hemolysis

Authors:

Abstract
No abstract available
Funding Information
  • Asahi Kasei Pharma (H27-j170)

This publication has 23 references indexed in Scilit: